Process for treating contact dermatitis

Abstract

Composition for topical administration comprising (a) a corticosteroid, and (b) a drying agent.

Description

REFERENCE TO RELATED APPLICATIONS [0001] This application is a continuation of Ser. No. 10 / 292,251, filed Nov. 12, 2002 which is a continuation of Ser. No. 09 / 652,811, filed Aug. 31, 2000, now U.S. Pat. No. 6,479,058 which claims the benefit of provisional application Ser. No. 60 / 152,068, filed Sep. 2, 1999.BACKGROUND OF THE INVENTION [0002] The present invention relates to a composition for the treatment of rashes, dermatoses or skin eruptions, which are known to be treated topically to improve or favorably alter the disease condition. Such rashes, dermatoses or skin eruptions include acute, inflammatory reactions of the skin caused by an allergic or irritant reaction (such as that caused by poison ivy, poison oak or poison sumac, or other forms of allergic or irritant contact dermatitis), other forms of eczema, lichen simplex chronicus, rashes, dermatoses or skin eruptions of a chronic nature (e.g. seborrheic dermatitis, psoriasis, atopic dermatitis) or caused by infection, irrita...

AI Technical Summary

Benefits of technology

"The present invention provides a composition for treating rashes, dermatoses, and skin eruptions. The composition contains a corticosteroid and a drying agent that can be easily applied to the skin. The composition promotes rapid drying of moist areas and coats the skin with the drying agent for protection and healing, especially for moist exudative rashes and rashes in moist areas."

Problems solved by technology

Irritants will cause an inelastic and stiff-feeling skin, discomfort due to dryness, pruritus secondary to inflammation, and pain due to fissures, blisters, and ulcers.

Chronic exposure to mild irritants or allergens results in dry, thickened, and fissured skin.

Strong irritants cause blistering, erosion, and ulcers of the skin.

If involvement is severe there may be marked edema, particularly of the face and in the periorbital and genital areas.

Individually these therapies do not bring rapid relief of all the symptoms of pruritus (itch), the inflammation of the dermatitis, as well as vesiculation and oozing.

But when used alone they typically do not provide relief from the inflammation caused by the dermatitis.

None of the above agents provide rapid drying of a moist, oozing rash while helping to absorb further moisture and keep the skin dry, and at the same time treat the contact dermatitis.

All of these conditions can present with a rash that can become moist, weeping, and quite irritated.

The rashes can also become secondarily infected.

Current therapeutic options do not always clear these conditions as rapidly as desired.